Table 4. Univariate and multivariate analysis of factors in patients with gastric cancer by Cox regression analysis.
Parameters | Overall survival | ||
---|---|---|---|
Univariate analysis | Multivariate analysis | ||
P-value | Hazard ratio (95% CI) | P-value | |
Gender (female vs. male) | 0.302 | 0.980 (0.586–1.638) | 0.938 |
Age (<65 vs. ≥65) | 0.021 | 1.688 (1.052–2.709) | 0.030 |
Tumor depth (T1/T2 vs. T3/T4) | <0.001 | 8.314 (2.973–23.247) | <0.001 |
LN metastasis (absent vs. present) | <0.001 | 1.510 (0.511–4.460) | 0.456 |
Distant metastasis (absent vs. present) | <0.001 | 3.016 (1.356–6.709) | 0.007 |
Histologic grade (WD/MD vs. PD/other) | 0.002 | 1.071 (0.407–2.820) | 0.890 |
Lauren classification (intestinal vs. diffuse/mixed) | 0.003 | 1.535 (0.572–4.119) | 0.395 |
Lymphatic invasion (absent vs. present) | <0.001 | 2.363 (0.905–6.170) | 0.079 |
Vascular invasion (absent vs. present) | <0.001 | 1.784 (1.051–3.030) | 0.032 |
Perineural invasion (absent vs. present) | <0.001 | 2.735 (1.572–4.761) | <0.001 |
LATS1 expression (high vs. low) | 0.038 | 1.039 (0.638–1.691) | 0.879 |
LATS2 expression (high vs. low) | 0.038 | 0.586 (0.306–1.119) | 0.105 |
LATS = large tumor suppressor; LN = lymph node; WD = well differentiated; MD = moderately differentiated; PD = poorly differentiated; CI = confidence interval.